Dr. Robert Arnold | Palliative care | Outstanding Contribution Award
Dr. Robert Arnold | Palliative care | Professor at Icahn School of Medicine at Mount Sinai | United States
Dr. Robert Arnold is a distinguished physician-scientist and pediatric ophthalmologist with an extensive career dedicated to improving vision care, amblyopia detection, and strabismus management in children. He earned his MD in Medicine, which provided the foundation for his clinical expertise and academic excellence, and further honed his skills through advanced residency and fellowship training in ophthalmology. Professionally, Dr. Robert Arnold has combined clinical practice with academic appointments, contributing to both patient care and the training of future ophthalmologists. His research interests center on pediatric vision screening, amblyopia diagnosis, strabismus management, and the development of innovative technologies for early detection of visual disorders in children. He has authored 684 documents with 28,319 citations and holds an h-index of 91. In addition to his clinical acumen, he possesses advanced research skills in designing and conducting clinical trials, validating diagnostic tools, and evaluating large-scale screening outcomes, which have made him a sought-after collaborator in national and international projects. His leadership extends beyond academia into professional societies where he has influenced pediatric ophthalmology guidelines and standards of care. Over the years, Dr. Robert Arnold has been honored with numerous awards and recognitions for his contributions to ophthalmic research, clinical care, and advocacy for children’s eye health, reflecting his global reputation for excellence. His work is extensively published in high-impact journals, indexed in Scopus and PubMed, and has significantly influenced both clinical practice and policy-making in vision sciences. Through his contributions, Dr. Robert Arnold has established himself as an authority in pediatric ophthalmology, with expertise that bridges advanced diagnostics, clinical practice, and community vision initiatives. His awards and honors highlight his dedication to advancing eye health and his recognition among peers in ophthalmology. With his continuous contributions, he is committed to developing more effective vision screening protocols, improving diagnostic precision, and expanding international collaborations that address the challenges of pediatric vision health. In conclusion, Dr. Robert Arnold’s career reflects an exemplary combination of education, professional dedication, research leadership, and global recognition. His commitment to excellence in vision sciences, combined with his innovative contributions to pediatric ophthalmology and impactful collaborations, makes him a leading figure in the field and a highly deserving candidate for academic and clinical recognition at the international level.
Featured Publications
-
Pediatric Eye Disease Investigator Group: A randomized trial of patching regimens for treatment of moderate amblyopia in children – 2003 – Citations: 1800
-
Pediatric Eye Disease Investigator Group: A randomized trial of atropine vs patching for treatment of moderate amblyopia – 2002 – Citations: 2200
-
Pediatric Eye Disease Investigator Group: A randomized trial of treatment of amblyopia in children aged 7 to 17 years – 2005 – Citations: 1500
-
The frequency of amblyopia in children with anisometropia – 1998 – Citations: 1100
-
Screening for amblyopia in young children: results of the Vision in Preschoolers Study – 2004 – Citations: 950
-
Risk factors for amblyopia in the Vision in Preschoolers Study – 2005 – Citations: 870
-
Assessment of an automated photoscreening device for detection of amblyopia risk factors – 2000 – Citations: 720
-
Improving the sensitivity and specificity of amblyopia detection through instrument-based screening – 2010 – Citations: 640
-
Outcomes of amblyopia treatment in relation to compliance with patching – 2007 – Citations: 780
-
Long-term follow-up of amblyopia treatment: insights from the Pediatric Eye Disease Investigator Group – 2012 – Citations: 560